Navigation Links
Pro-Dex, Inc. Appoints Harold A. Hurwitz as Chief Financial Officer
Date:10/6/2010

IRVINE, Calif., Oct. 6 /PRNewswire-FirstCall/ -- PRO-DEX, INC. (Nasdaq: PDEX) today announced the appointment of Harold A. ("Hal") Hurwitz as Chief Financial Officer, effective October 6, 2010.  Mr. Hurwitz succeeds Jeffrey J. Ritchey who has left the Company.

"Hal comes to Pro-Dex with a broad financial background that includes Big 4 public accounting experience as a Partner with Coopers & Lybrand LLP, now part of PricewaterhouseCoopers LLP, as well as public and private company financial management responsibility," commented Mark Murphy, Pro-Dex's Chief Executive Officer.  "We are delighted to have Hal on our team to help accomplish the goals we have established."  Commenting on Mr. Ritchey, Mr. Murphy continued, "On behalf of the entire Board of Directors, I want to thank Jeff for his dedication to Pro-Dex over the last nine years.  We greatly appreciate the contributions he has made, particularly in having served the company in multiple capacities during its development.  We wish him well in his future endeavors."

"I am privileged to be joining Pro-Dex at this exciting time," said Mr. Hurwitz. "Pro-Dex's ability to strengthen itself even through the uncertainties of the recent economic environment is impressive, and I look forward to being part of the leadership team that continues to build upon these strengths to position the company for future growth."

Through February 2010, Mr. Hurwitz was Vice President and Chief Financial Officer for Interventional Spine Inc., a medical device company focused on percutaneous systems for treatment of back pain.  Prior to that, he was a Principal Consultant with McDermott & Bull, a retained executive search firm where he specialized in serving the life science industry.   From 1997 through 2004, Mr. Hurwitz was Vice President and Chief Financial Officer for Micro Therapeutics, Inc., a developer and manufacturer of interventional neurovascular medical devices.  Mr. Hurwitz began his career with Coopers & Lybrand LLP, where he served for 22 years, leading its life science and high technology practices in Orange County.  

Pro-Dex, Inc., with operations in California, Oregon and Nevada, specializes in bringing speed to market in the development and manufacture of technology-based solutions that incorporate miniature rotary drive systems, embedded motion control and fractional horsepower DC motors, serving the medical, dental, semi-conductor, scientific research and aerospace markets.  Pro-Dex's products are found in hospitals, dental offices, medical engineering labs, commercial and military aircraft, scientific research facilities and high tech manufacturing operations around the world.  For more information, visit the Company's website at www.pro-dex.com.

Statements herein concerning the Company's plans, growth and strategies may include 'forward-looking statements' within the context of the federal securities laws. Statements regarding the Company's future events, developments and future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements within the meaning of these laws. The Company's actual results may differ materially from those suggested as a result of various factors. Interested parties should refer to the disclosure concerning the operational and business concerns of the Company set forth in the Company's filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Pro-Dex, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pro-Dex, Inc. Announces Fiscal 2010 Third Quarter Financial Results Conference Call and Webcast
2. Pro-Dex, Inc. Announces Fiscal Second Quarter 2010 Results
3. Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customers Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders
4. PRO-DEX, INC. Announces Fiscal First Quarter 2010 Profit, Update on Business Development Activities, and Renewal of Banking Agreement
5. Accera, Inc. Appoints Dr. Thomas Werner President & CEO and Announces FDA Acceptance of IND Application for AC-1204 for Mild-to-Moderate Alzheimers Disease
6. Intercell AG Appoints Staph Leavenworth Bakali as Chief Business Officer
7. 3-V Biosciences Appoints Merdad V. Parsey, MD, PhD, as Chief Executive Officer
8. Tigris Pharmaceuticals Appoints Neil Flanzraich to Executive Chairman of the Board
9. Laureate Pharma Appoints Steven R. Johnson as Vice President, Business Development
10. BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors
11. Kinetic Systems Appoints Peter M. Maris President & Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
(Date:4/20/2017)... , April 20, 2017 Research and ... Pharmaceutical Contract Manufacturing Services Market Analysis By Service (Manufacturing, Research), ... Forecasts, 2014 - 2025" report to their offering. ... The Latin American pharmaceutical ... billion by 2025 Low drug registration cost in ...
(Date:4/19/2017)... Cardiology devices segment is anticipated to reach the highest market ... segment is likely to create absolute $ opportunity of a ... By the end of 2027, Cardiology Devices segment is projected ... expanding at a CAGR of 18.4% over the forecast period. ... reprocessed medical devices market in terms of revenue ...
Breaking Medicine Technology:
(Date:4/25/2017)... , ... April 25, 2017 , ... Lake Park Dental ... by using Invisalign® in Lutz, FL. With the help of this highly-effective, ... aesthetics with fewer potential complications, more discretion and less pain. , Drs. Sarah ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... Buyers and ... recreational users to dispensaries and head shops –can’t help but be heartened by the ... the tell-tale cannabis odor aptly described as “skunk smell.” At last they can ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at this ... joint health in horses at the immunologic level. , The scientifically-developed Flexadin UCII ...
(Date:4/24/2017)... ... April 24, 2017 , ... The Santana Telehealth Project was honored with the ... the American Telemedicine Association’s annual conference, on April 23 in Orlando, FL. , “I ... improve the lives of the poor and underserved in other parts of the world,” ...
(Date:4/24/2017)... ... ... Bright Pink , a national non-profit organization focusing on the prevention and early detection ... Pink is proud to announce Katie Thiede as their new Chief Executive Officer. In January, ... Chairman of the Board and launched a national search to find a visionary new leader ...
Breaking Medicine News(10 mins):